Cannabis … in wafer form?

Clinical trials of cannabis sublingual wafers begin this week after approval by the TGA A clinical trial of a unique ‘cannabis wafer product’ has been approved by the TGA, with first patient visits commencing on Tuesday. Developer and distributor of skincare and health supplements, Bod Australia, announced the commencement of its Phase I Clinical trial

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous CWH calls for urgent ownership rules reform
Next Off the grid